RXi Pharmaceuticals Corporation (RXII) dropped -14.6% or -0.47 to $2.75. It is nearly 138889 shares traded, which is 32.19% compare to the average total volume 431424. The market cap of RXII is $7.14 million. The year to date change is -41.45%. The 52 week price range is from $2.51 to $8.5. Price of RXII have changed -20.88% during last week. It have changed 15.00% over last month, -42.07% over last 3 months, -32.92% over last 6 months and -62.56% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RXII is 3.69. It is 34.18% above current price. The 200-day Moving Averages for RXII is 5.20. It is 89.09% above current price. The 52-week High is 8.5. It is 209.09% from the current price. The 52-week Low is 2.51. It is -8.73% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of RXII is 0.51 on 2018-03-15. Short % to float is 16.68%. There are some statistics of RXII. It is has market cap $7.14 million. The share outstanding is 2.59 million. The average volume is 431424. The percent of top 15 Institution holding is 0.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RXII is -244.28%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RXII is -128.50%.